Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.
Patchy white matter hyperintensity in ring chromosome 18 syndrome.
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis.
Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
Lateral flow immunoassay with upconverting nanoparticle-based detection for indirect measurement of interferon response by the level of MxA.
Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NO.
Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies.
Rituximab for treating multiple sclerosis: Off-label but on target.
Role of FET proteins in neurodegenerative disorders.
Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in Tears.
Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis.
Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex.
Extracranial Head and Neck Schwannomas: Our Experience.
Anesthetic management of a patient with multiple sclerosis - case report.
Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
Tumefactive demyelinating brain lesions with multiple closed-ring enhancement in the course of neuromyelitis optica.
IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo.
Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Diagnostic Yield and Safety of Brain Biopsy for Suspected Primary Central Nervous System Angiitis.
A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression.
Pages
« first
‹ previous
…
763
764
765
766
767
768
769
770
771
…
next ›
last »